Market Trend Report: VR therapeutics for medical device leaders
We outline the market outlook for VR therapeutics in the medical device industry — from investment trends, to leading companies, to recommendations for the players in the space.
Digital Therapeutics
What are Cigna and Elevance Health doing in digital therapeutics?
As payers look for innovative ways to improve care at a lower cost, Cigna and Elevance Health (formerly Anthem) are exploring opportunities in digital therapeutics.
What pharma and CRO leaders need to know about digital therapeutics for diabetes
We outline the market outlook for diabetes DTx in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for players in the space.
How tech is making women’s healthcare more equitable and accessible
Women are pushing back against a healthcare system that has largely ignored their specific needs, creating a broad space for startups offering women-focused solutions. From next-gen cancer screening to AI-powered fertility trackers, here's the technology transforming women’s healthcare.
Market Trend Report: Chronic pain digital therapeutics for healthcare leaders
We outline the market outlook for chronic pain digital therapeutics in healthcare – from investment trends, to leading companies, to recommendations for players in the space.
Prioritizing 9 precision medicine technologies helping pharma leaders offer better patient outcomes
From real-world data to digital therapeutics, this MVP Technology Framework evaluates the tech solutions pharmaceutical companies and contract research organizations (CROs) like Pfizer and IQVIA are using to develop and deliver personalized medicine.
Market Trend Report: Sleep Digital Therapeutics for Healthcare Leaders
We outline the market outlook for sleep digital therapeutics in healthcare — from investment trends, to leading companies, to recommendations for players in the space.
Unbundling Women’s Health: How femtech is disrupting traditional women’s health & wellness services
From fertility to menopause, we take a look at the femtech startups disrupting women's health.
Analyzing Microsoft’s growth strategy: How the OS titan is building a new foundation for healthcare
We mined Microsoft's acquisitions, investments, and partnerships to discern the company's strategic priorities.
70+ early-stage companies revolutionizing the medical device market
From computer-aided diagnostic imaging to point-of-care testing to surgical intelligence, these early-stage startups are making medical devices smarter, faster, and more accurate.
How healthcare leaders should prioritize these 15 digital therapeutic tech markets
Healthcare leaders are looking for ways to help patients avoid traditionally costly and physically taxing medication and surgery. From diabetes to ADD & ADHD, we take a look at the digital therapeutic areas that leaders should focus on to address this challenge immediately and down the road.
Virtual treatment service for opioid addiction raises $50M. Bicycle Health competitors are Eleanor Health, Ophelia, opiAID, Boulder Care, and Spero Recovery Center.
The funding will help Bicycle Health increase the reach of its care. Here are the top-line bullets you need to know.
Parallel Learning, a telepsychiatry service for children, raises $20M from investors including Tiger Global and Obvious Ventures. Parallel Learning competitors are ADHD Online and Array Behavioral Health.
The funding will help Parallel Learning fuel national expansion. Here are the top-line bullets you need to know.
Sidekick Health, which offers digital therapeutics for chronic disease management, raises $55M. Sidekick Health competitors are Albert Health, Amalgam Rx, DosentRx, smartpatient, Vitadio, and Voluntis.
The funding will help Sidekick Health expand into new therapeutic areas. Here are the top-line bullets you need to know.
Analyzing CVS Health’s growth strategy: How the $141B pharmacy giant is reinforcing its hold on healthcare
We mined CVS Health’s acquisitions, investments, and partnerships to discern the company's strategic priorities.
Pediatric mental health platform Brightline hits $705M valuation in financing led by KKR. Brightline competitors in the pediatric behavioral health industry include Cognoa, Elemy, Joon Care, Little Otter, Lyra Health, and Thallos.
Brightline plans to use the funds to expand its team and offerings. Here are the top-line bullets you need to know.
Omada Health hits $1B valuation for its virtual care platform for chronic conditions such as diabetes and hypertension. Omada Health competitors include Livongo Health, Noom, and Lark.
This news comes on the heels of its Series E round. The company plans to use the funding to accelerate its technological roadmap for care and coaching personalization. Here are the top-line bullets you need to know.
Direct-to-patient healthcare provider Ro hits $7B valuation. Ro competitors include Numan, Pill Club, Thirty Madison, Maximus, and NURX.
This news comes on the heels of its Series E funding round. Ro intends to use the funding to expand its B2B offerings. Here are the top-line bullets you need to know.
Computational drug discovery platform Terray Therapeutics raises $60M from Madrona. Terray competitors include Verge Genomics, Certara, Insilico Medicine, Atomwise, Recursion, and Benevolent AI.
Terray Therapeutics plans to use the funds to advance its preclinical therapeutics pipeline and its proprietary tNova platform. Here are the top-line bullets you need to know.
Analyzing Amazon’s healthcare growth strategy: How the tech giant is shaping the future of the $5T industry
Investment Thesis Map
We mined Amazon's acquisitions, investments, and partnerships to discern the company's strategic priorities in healthcare.
Analyzing Johnson & Johnson’s Growth Strategy: How The Pharma Giant Is Going Digital
Investment Thesis Map
We mined Johnson & Johnson’s acquisitions, investments, and partnerships to discern the company's strategic priorities.
Tech Market Map Report — Digital Therapeutics In Healthcare
This report looks at the digital therapeutic companies serving the healthcare industry.
LabCorp Acquires Cancer Genomics And Liquid Biopsy Company Personal Genome Diagnostics (PGDx) For $450M — A 20.5x Price/Revenue Valuation Multiple
With the acquisition, LabCorp plans to enhance its liquid biopsy and NGS-based genomic profiling capabilities. Here are the top-line bullets you need to know.
Virtual Addiction Treatment Technology Provider Ophelia Hits $275M Valuation As It Competes With WorkIt Health, Bicycle Health, Boulder Care, Groups, And Quit Genius
This news comes on the heels of its Series B funding round. It plans to use the funds to fuel US expansion. Here are the top-line bullets you need to know.
Our Top 2021 Healthcare Reports
The pandemic has forced us to reimagine all aspects of healthcare delivery. Discover what’s changed across telehealth, digital therapeutics, medical devices, and more.
Cadence Hits A $1B Valuation In The Crowded Remote Patient Monitoring (RPM) Market. It Competes With Current Health, Huma, Doccla, Spire Health, And Numerous Other RPM Companies.
This news comes on the heels of its Series B round. It plans to use the funding to provide more personalized remote patient care. Here are the top-line bullets you need to know.